$7.69
Vir Biotechnology is a biotechnology business based in the US. Vir Biotechnology shares (VIR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.75 – an increase of 5.73% over the previous week. Vir Biotechnology employs 587 staff and has a trailing 12-month revenue of around $78.9 million.
Our top picks for where to buy Vir Biotechnology stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Vir Biotechnology stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – VIR. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Vir Biotechnology stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Vir Biotechnology stock price (NASDAQ: VIR)
Use our graph to track the performance of VIR stocks over time.Vir Biotechnology shares at a glance
Latest market close | $7.75 |
---|---|
52-week range | $7.12 - $13.09 |
50-day moving average | $8.03 |
200-day moving average | $9.40 |
Wall St. target price | $33.86 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-3.70 |
Is it a good time to buy Vir Biotechnology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Vir Biotechnology price performance over time
Historical closes compared with the close of $7.67 from 2024-10-14
1 week (2024-10-10) | 4.50% |
---|---|
1 month (2024-09-17) | -3.28% |
3 months (2024-07-17) | -25.32% |
6 months (2024-04-17) | -7.03% |
1 year (2023-10-17) | -10.29% |
---|---|
2 years (2022-10-17) | -64.49% |
3 years (2021-10-15) | 39.09 |
5 years (2019-10-17) | 14.22 |
Vir Biotechnology financials
Revenue TTM | $78.9 million |
---|---|
Gross profit TTM | $1 billion |
Return on assets TTM | -16.55% |
Return on equity TTM | -29.78% |
Profit margin | 0% |
Book value | $10.50 |
Market Capitalization | $1 billion |
TTM: trailing 12 months
Vir Biotechnology share dividends
We're not expecting Vir Biotechnology to pay a dividend over the next 12 months.
Vir Biotechnology share price volatility
Over the last 12 months, Vir Biotechnology's shares have ranged in value from as little as $7.12 up to $13.09. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vir Biotechnology's is 0.455. This would suggest that Vir Biotechnology's shares are less volatile than average (for this exchange).
Vir Biotechnology overview
Vir Biotechnology, Inc. , an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc. ; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd. ; and a collaborative research agreement with GlaxoSmithKline Biologicals S.
Frequently asked questions
What percentage of Vir Biotechnology is owned by insiders or institutions?Currently 11.51% of Vir Biotechnology shares are held by insiders and 75.109% by institutions. How many people work for Vir Biotechnology?
Latest data suggests 587 work at Vir Biotechnology. When does the fiscal year end for Vir Biotechnology?
Vir Biotechnology's fiscal year ends in December. Where is Vir Biotechnology based?
Vir Biotechnology's address is: 1800 Owens Street, San Francisco, CA, United States, 94158 What is Vir Biotechnology's ISIN number?
Vir Biotechnology's international securities identification number is: US92764N1028 What is Vir Biotechnology's CUSIP number?
Vir Biotechnology's Committee on Uniform Securities Identification Procedures number is: 92764N102
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question